Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank85
5Y CAGR+2.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+2.1%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 25.87% |
| 2024 | 64.39% |
| 2023 | 28.64% |
| 2022 | -22.63% |
| 2021 | -22.00% |
| 2020 | 23.29% |
| 2019 | -31.07% |
| 2018 | -105.45% |
| 2017 | -45.78% |
| 2016 | -61.55% |